vs
Ascendis Pharma A/S（ASND）与UiPath, Inc.（PATH）财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是Ascendis Pharma A/S的1.5倍（$411.1M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs 15.9%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 0.7%）
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
ASND vs PATH — 直观对比
营收规模更大
PATH
是对方的1.5倍
$267.3M
营收增速更快
ASND
高出26.4%
15.9%
两年增速更快
ASND
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $267.3M | $411.1M |
| 净利润 | — | $198.8M |
| 毛利率 | 90.5% | 83.3% |
| 营业利润率 | — | 3.2% |
| 净利率 | — | 48.4% |
| 营收同比 | 42.3% | 15.9% |
| 净利润同比 | — | 1966.2% |
| 每股收益（稀释后） | — | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASNDPATH
| Q4 25 | $267.3M | $411.1M | ||
| Q3 25 | $230.7M | $361.7M | ||
| Q2 25 | $170.7M | $356.6M | ||
| Q1 25 | $109.0M | $423.6M | ||
| Q4 24 | $187.8M | $354.7M | ||
| Q3 24 | $62.5M | $316.3M | ||
| Q2 24 | $38.9M | $335.1M | ||
| Q1 24 | $103.6M | $405.3M |
净利润ASNDPATH
| Q4 25 | — | $198.8M | ||
| Q3 25 | $-65.9M | $1.6M | ||
| Q2 25 | $-42.0M | $-22.6M | ||
| Q1 25 | $-102.2M | $51.8M | ||
| Q4 24 | — | $-10.7M | ||
| Q3 24 | $-107.1M | $-86.1M | ||
| Q2 24 | $-118.1M | $-28.7M | ||
| Q1 24 | $-141.5M | $33.9M |
毛利率ASNDPATH
| Q4 25 | 90.5% | 83.3% | ||
| Q3 25 | 89.5% | 82.2% | ||
| Q2 25 | 80.1% | 82.1% | ||
| Q1 25 | 82.6% | 84.8% | ||
| Q4 24 | 91.9% | 82.0% | ||
| Q3 24 | 80.6% | 80.0% | ||
| Q2 24 | 68.2% | 83.5% | ||
| Q1 24 | 92.1% | 86.8% |
营业利润率ASNDPATH
| Q4 25 | — | 3.2% | ||
| Q3 25 | 5.1% | -5.6% | ||
| Q2 25 | -33.5% | -4.6% | ||
| Q1 25 | -103.2% | 7.9% | ||
| Q4 24 | — | -12.2% | ||
| Q3 24 | -167.3% | -32.7% | ||
| Q2 24 | -370.2% | -14.8% | ||
| Q1 24 | -51.2% | 3.7% |
净利率ASNDPATH
| Q4 25 | — | 48.4% | ||
| Q3 25 | -28.5% | 0.4% | ||
| Q2 25 | -24.6% | -6.3% | ||
| Q1 25 | -93.7% | 12.2% | ||
| Q4 24 | — | -3.0% | ||
| Q3 24 | -171.5% | -27.2% | ||
| Q2 24 | -303.9% | -8.6% | ||
| Q1 24 | -136.6% | 8.4% |
每股收益（稀释后）ASNDPATH
| Q4 25 | — | $0.37 | ||
| Q3 25 | — | $0.00 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $0.09 | ||
| Q4 24 | — | $-0.02 | ||
| Q3 24 | — | $-0.15 | ||
| Q2 24 | — | $-0.05 | ||
| Q1 24 | — | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $665.3M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-175.8M | $1.9B |
| 总资产 | $1.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASNDPATH
| Q4 25 | $665.3M | $1.4B | ||
| Q3 25 | $582.2M | $1.4B | ||
| Q2 25 | $533.6M | $1.6B | ||
| Q1 25 | $559.4M | $1.6B | ||
| Q4 24 | $604.3M | $1.6B | ||
| Q3 24 | $675.6M | $1.7B | ||
| Q2 24 | $279.4M | $1.9B | ||
| Q1 24 | $345.9M | $1.9B |
股东权益ASNDPATH
| Q4 25 | $-175.8M | $1.9B | ||
| Q3 25 | $-188.0M | $1.7B | ||
| Q2 25 | $-202.6M | $1.7B | ||
| Q1 25 | $-205.0M | $1.8B | ||
| Q4 24 | $-114.2M | $1.7B | ||
| Q3 24 | $-105.1M | $1.8B | ||
| Q2 24 | $-346.8M | $2.0B | ||
| Q1 24 | $-257.2M | $2.0B |
总资产ASNDPATH
| Q4 25 | $1.4B | $2.9B | ||
| Q3 25 | $1.2B | $2.6B | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.1B | $2.9B | ||
| Q4 24 | $1.3B | $2.7B | ||
| Q3 24 | $1.2B | $2.7B | ||
| Q2 24 | $819.0M | $2.8B | ||
| Q1 24 | $866.7M | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.2M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | — | $25.1M |
| 自由现金流率自由现金流/营收 | — | 6.1% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.14× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASNDPATH
| Q4 25 | $58.2M | $28.3M | ||
| Q3 25 | — | $41.6M | ||
| Q2 25 | — | $119.0M | ||
| Q1 25 | $-15.5M | $146.1M | ||
| Q4 24 | $-330.7M | $28.1M | ||
| Q3 24 | — | $46.4M | ||
| Q2 24 | — | $100.0M | ||
| Q1 24 | $-109.7M | $145.6M |
自由现金流ASNDPATH
| Q4 25 | — | $25.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $106.2M | ||
| Q1 25 | — | $138.7M | ||
| Q4 24 | — | $23.2M | ||
| Q3 24 | — | $45.0M | ||
| Q2 24 | — | $98.8M | ||
| Q1 24 | — | $141.8M |
自由现金流率ASNDPATH
| Q4 25 | — | 6.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 29.8% | ||
| Q1 25 | — | 32.7% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | — | 29.5% | ||
| Q1 24 | — | 35.0% |
资本支出强度ASNDPATH
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 3.6% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.9% |
现金转化率ASNDPATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 26.25× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.82× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASND
暂无分部数据
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
